Key facts
- This page summarizes William C. Weldon's Form 3 filing for Heartflow, Inc. (HTFL).
- 0 reported transactions and 9 derivative rows are listed below.
- Accepted by SEC: 07 Aug 2025, 21:14.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
The number of shares of common stock and exercise price, as applicable, give effect to the 1-for-2.92 reverse stock split of Heartflow, Inc.'s ("Heartflow") common stock, which became effective on July 31, 2025.
Footnote F2
These stock options are fully exercisable.
Footnote F3
The option is vested and exercisable as to 28,520 shares, and the remaining shares will vest and become exercisable in monthly installments until March 25, 2026, subject to continued service through the applicable vesting date.
Footnote F4
The option will vest 100% on the one-year anniversary of the closing of Heartflow's initial public offering.
Footnote F5
The option is vested and exercisable as to 13,482 shares, and the remaining shares will vest and become exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date.
Footnote F6
The option is vested and exercisable as to 19,973 shares, and the remaining shares will vest and become exercisable in monthly installments until September 26, 2027, subject to continued service through the applicable vesting date.
Footnote F7
Each share of Series D preferred stock is convertible on a 1-to-0.6467 basis into shares of Heartflow's common stock and has no expiration date. The Series D preferred stock will automatically convert into the underlying shares of common stock upon the closing of Heartflow's initial public offering. The conversion rate gives effect to the 1-for-2.92 reverse stock split of Heartflow's common stock, which became effective on July 31, 2025.
Footnote F8
Each share of Series F preferred stock and Series F-1 preferred stock is convertible on a 1-to-0.3425 basis into shares of Heartflow's common stock and has no expiration date. The Series F preferred stock and Series F-1 preferred stock will automatically convert into the underlying shares of common stock upon the closing of Heartflow's initial public offering. The conversion rate gives effect to the 1-for-2.92 reverse stock split of Heartflow's common stock, which became effective on July 31, 2025.
SEC remarks
Exhibit 24 - Power of Attorney.